Q4 2025 Earnings Call Transcript June 17, 2025 VistaGen Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.43, expectations were $-0.52. Operator: Good day, everyone, and thank you ...

Makary and Center for Biologics Evaluation and Research Director Vinay Prasad unveiled a new framework in the New England ...